Palmitoyl Hexapeptide-12

Palmitoyl Hexapeptide-12 is a synthetic lipopeptide developed by Sederma under the trade name Biopeptide EL. It is an elastin-signaling peptide designed to stimulate the production of tropoelastin -- the soluble precursor to elastin -- in dermal fibroblasts.

Overview

Elastin is a critical structural protein in the dermis that provides skin with its ability to snap back after stretching. Unlike collagen, which provides tensile strength, elastin confers resilience and flexibility. Elastin production declines sharply after puberty, and existing elastin fibers degrade progressively through UV exposure, enzymatic activity, and normal aging. Unlike collagen, the body has very limited capacity to replace damaged elastin in adult skin.

Palmitoyl Hexapeptide-12 was developed to address this gap. The peptide sequence is derived from elastin-related signaling fragments and is conjugated to a palmitic acid chain to enhance dermal penetration. By stimulating fibroblasts to produce new tropoelastin, Biopeptide EL aims to partially restore the elastic fiber network that underpins youthful skin mechanics.

In clinical testing, formulations containing Palmitoyl Hexapeptide-12 demonstrated measurable improvements in skin elasticity parameters, including increased elastic recovery and reduced sagging in treated areas. The peptide is typically used at low concentrations (1-5 ppm) in cosmetic formulations targeting mature or sun-damaged skin.

Mechanism of Action

Palmitoyl Hexapeptide-12 functions through the elastin receptor complex (ERC), a heterotrimeric receptor present on fibroblasts, keratinocytes, and smooth muscle cells. The hexapeptide sequence VGVAPG is a repeating motif found within native elastin and acts as a matrikine when released during elastin turnover.

When Palmitoyl Hexapeptide-12 binds to the elastin-binding protein (EBP) component of the ERC, it triggers intracellular signaling cascades involving protein kinase C and MAP kinase pathways. This stimulates transcription of the tropoelastin gene (ELN), increasing production of soluble tropoelastin monomers. These monomers are secreted, cross-linked by lysyl oxidase, and assembled into mature elastic fibers in the extracellular matrix.

The palmitoyl chain serves a dual purpose: it enhances penetration through the stratum corneum by increasing lipophilicity, and it may protect the peptide from rapid enzymatic degradation in the dermal environment. The peptide's mechanism complements collagen-stimulating peptides like Matrixyl, as both elastin and collagen are required for optimal skin mechanical properties.

Reconstitution Calculator

Research

Safety Profile

Palmitoyl Hexapeptide-12 has an established safety profile for topical cosmetic use. Patch testing and repeated insult studies show no irritation, sensitization, or phototoxicity at recommended concentrations. The peptide is compatible with standard cosmetic bases and stable under typical storage conditions. Systemic exposure from topical application is negligible. No adverse effects have been reported in published clinical studies. The VGVAPG sequence is derived from endogenous human elastin, supporting its biocompatibility.

Pharmacokinetic Profile